테스토스테론 치료와 연관된 중심성 장액맥락망막병증 1례

Abstract

Purpose: We experienced a development of central serous chorioretinopathy (CSC) in a patient who had taken testosterone therapy, so we report this case with a review of the literatures. Case summary: A 46-year old male who was on intramuscular testosterone-Enenthate 250mg/month for 4 years presented to our eye clinic for central serous retinal detachement with repetition of remission and relapse for 3 years. Fundus examination, fluorescein angiography, optical coherence tomography were perfomed to check the change. Three months after stoping intramuscular testosterone therapy, serous retinal detachment was completely resolved, and it maintained for 1 year. Conclusions: Testosterone possibly involve in the pathogenesis of CSC, it is important that fundus examinations have to be performed periodically in case of systemic testosterone therapy.